Stock listing

Supernus Pharmaceuticals, Inc.

Selected listing: 0LB2 · LSE · USD · GB

Supernus Pharmaceuticals, Inc. (LSE:0LB2), Health Technology. Latest release Aug 31, 2026: Chloe Kim Teams Up with Qelbree®, the 1 Prescribed Branded…

0LB2:LSEUSDGBUpdated October 2, 2026

Ticker: LSE:0LB2
Asset type: Stock
Sector: Health Technology
Industry: Pharmaceuticals: Major
Exchange: LSE
Currency: USD

Latest news from Supernus Pharmaceuticals, Inc.

Chloe Kim Teams Up with Qelbree®, the #1 Prescribed Branded Non-Stimulant ADHD Treatment*, to Help Empower People Navigating ADHD

August 31, 2026

Supernus Pharmaceuticals Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Supernus Pharmaceuticals, Inc. - SUPN

August 7, 2026

Supernus Announces Second Quarter 2026 Financial Results

August 3, 2026

Supernus Pharmaceuticals and Indivior Pharmaceuticals to Merge, Creating a Diversified CNS Biopharmaceutical Leader with Significant Scale

August 3, 2026

Supernus Pharmaceuticals to Announce Second Quarter 2026 Financial Results and Host Conference Call on August 4, 2026

July 22, 2026

All Supernus Pharmaceuticals, Inc. news →

Events

Replays

Supernus Pharmaceuticals, Inc. (SUPN) Q2 2026 Earnings Call
Tue, Aug 04, 2026 · 04:30 PM ET
Watch
Supernus Pharmaceuticals, Inc. (SUPN) Q1 2026 Earnings Call
Tue, May 05, 2026 · 04:30 PM ET
Watch
Supernus Pharmaceuticals, Inc. (SUPN) Q4 2025 Earnings Call
Tue, Feb 24, 2026 · 04:30 PM ET
Watch

Research Supernus Pharmaceuticals, Inc.

Supernus Pharmaceuticals, Inc. company profile

View the public company page for Supernus Pharmaceuticals, Inc. on 6ix.

Supernus Pharmaceuticals, Inc. news

Read company news and market updates connected to Supernus Pharmaceuticals, Inc..

Supernus Pharmaceuticals, Inc. investor events

Find investor webinars, events, and replay context for Supernus Pharmaceuticals, Inc..